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Abstract At present, evidence for a plethora of physiological
roles for the different classes of peptidyl-prolyl-cis/trans-
isomerases (PPIases, EC 5.2.1.8) is emerging. Cyclosporin A
(CyA) has been previously reported to disrupt memory formation
in a temporally specific manner, when administered intracra-
nially to day-old chicks trained on a single-trial, passive-
avoidance task [Bennett, P.C., Zhao, W., Lawen, A. and Ng,
K.T. (1996) Brain Res. 730, 107^117]. CyA is known to inhibit
both the PPIase activity of cyclophilin and, indirectly, the protein
phosphatase activity of calcineurin. Therefore to begin to
distinguish between these two functions we studied the effects
on memory formation of three non-immunosuppressive CyA
analogues, in order to study the involvement of cyclophilins.
These drugs retain the capacity to bind to and inhibit the PPIase
activity of cyclophilin, but do not bind in the complex with
cyclophilin to calcineurin and, therefore, do not inhibit its
phosphatase activity. All three drugs exert effects on memory
formation comparable to those induced by CyA, significantly
inhibiting memory formation when injected intracranially (50
fmol per hemisphere) immediately following training. Brain
extracts from chicks treated with [MeVal4]CyA show a strong
inhibition of cyclophilin activity. These data show a requirement
for the PPIase activity of a cyclophilin for successful memory
formation and constitute the first set of data establishing a
physiological role for a cyclophilin.
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1. Introduction
The immunosuppressant cyclosporin A (CyA) impairs T
cell proliferation by inhibiting the activity of the calcium/
calmodulin-dependent protein serine/threonine phosphatase
calcineurin (CaN) [1,2]. More speci¢cally, CyA has been
found to bind to a class of cytosolic receptor proteins called
cyclophilins. The cyclophilin/CyA complex then binds to
CaN, inhibiting the activity of this enzyme and preventing
the calcium-dependent translocation of the p88 subunit of
transcription factor NF-AT to the nucleus, where it is re-
quired for T-cell activation [3]. This ¢nding has proven to
be particularly important for molecular biologists since, in
addition to elucidating one mechanism responsible for phar-
macological immunosuppression, it also suggests that the cell-
permeable CyA may be suitable as an agent with which to
investigate other cellular functions of CaN, an enzyme postu-
lated to have important functions in various tissues [4,5]. As a
result, both CyA and an alternative immunosuppressant,
FK506, which acts via a similar mechanism of ¢rst binding
to a class of cytosolic receptor proteins and subsequently
binding to and inhibiting CaN [1,2], have recently been used
to probe the involvement of CaN in various aspects of cell
biology [6]. Since the mechanism of action can be either the
direct inhibition of cyclophilin or the indirect inhibition of
CaN, employment of non-immunosuppressive CyA analogues
has proved a powerful tool for discriminating between pep-
tidyl-prolyl-cis/trans-isomerase (PPIase) and CaN inhibition
[7,8].
Most of the reported e¡ects of CyA so far have been at-
tributed to its inhibition of CaN, upon binding to its receptor
proteins, the cyclophilins. Evidence is emerging, however,
which identi¢es various physiological roles for the cyclophilins
themselves. Several e¡ects of CyA have been found to be
mediated by inhibition of PPIase activity rather than by in-
hibition of CaN activity, including neurotrophic action [9],
transport into the mitochondrion [10], and inhibition of rep-
lication of HIV-1 [7,11]. It was previously reported that intra-
cranial administration of nanomolar concentrations of CyA
signi¢cantly impairs long-term memory formation in neonate
chicks trained on an established, single-trial, passive-avoid-
ance task [12]. Importantly, groups of chicks tested up to 60
min post training demonstrated normal retention levels, while
all groups tested 80 min after training, or at any time later up
to 24 h, displayed signi¢cant retention de¢cits. Thus, it would
appear that administration of CyA, at the time and concen-
tration employed, selectively disrupts only later stages of
memory formation, leaving earlier stages intact. No retention
de¢cits were apparent following administration of CyH, a
CyA analogue which does not bind to cyclophilin nor inhibit
CaN [12]. Because CyA could a¡ect memory through inhib-
ition of either CaN or cyclophilin activity, to begin to clarify
the mechanism responsible for the amnestic e¡ect of CyA, the
e¡ects of three non-immunosuppressive CyA analogues,
namely [MeVal4]CyA, [MeIle4]CyA and [MeAla6]CyA, on
memory formation in the chick were investigated. Each of
these agents is reported to bind to cyclophilin and inhibit its
PPIase activity, but the resulting complex has no e¡ect on the
activity of CaN [6]. These compounds therefore are only ef-
fective against the cyclophilin itself, without a¡ecting calci-
neurin. All three compounds showed an amnestic e¡ect at
similar concentrations and times as CyA itself. While this
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does not eliminate the possibility that CaN may also play a
role in memory formation, our data provide the ¢rst available
evidence of an important, physiological role for cyclophilin
activity.
2. Materials and methods
2.1. Animals
In all experiments chicks were trained using a passive-avoidance
task described in detail elsewhere [13]. Brie£y, groups of 20 chicks
with two chicks per training box were pre-trained to peck at various
colored beads. Each chick was then presented with a red bead coated
with an aversive chemical, methylanthranilate. After pecking at this
bead all chicks typically demonstrated a strong disgust reaction, emit-
ting distress calls and wiping their beaks on the £oor of the cage. At
speci¢ed times following the aversive training experience, each chick
was administered the required concentration of the appropriate agent.
All drugs were dissolved in EtOH and diluted in physiological saline
before being administered freehand (10 Wl per hemisphere) bilaterally
into the hyperstriatal/neostriatal complex of the chick brain, using a
Hamilton repeating dispenser syringe ¢tted with a plastic sleeve to
limit injection depth to 3.5 mm. This area of the chick brain is known
to be metabolically active following passive-avoidance training [14,15].
Random histological checks were used to con¢rm the accuracy of all
injections (s 85% within 1 mm of the target site), with the 10 Wl
volume being selected on the basis of many previous experiments
showing that this volume is most suited to the loose architecture of
the neonate chick brain. Control groups were administered a 5 nM
concentration of CyH (= 50 fmol), a CyA analogue which does not
bind to cyclophilin nor inhibit CaN [12], which was also dissolved in
EtOH and diluted in saline. Retention for the aversive training expe-
rience was tested at the required time following training by presenting
each chick with a red bead for 10 s, followed by a blue bead for 10 s.
The number of pecks at each bead was recorded for each chick. Data
from chicks which failed to train or peck the blue bead at test were
eliminated before a discrimination ratio (DR), de¢ned as the ratio
between the number of pecks at the blue bead and the number of
pecks at both red and blue beads, was calculated for each chick. The
mean DR for each group of chicks was calculated, with good discrim-
ination between the two colored beads leading to a mean DR ap-
proaching 1.0 and poor discrimination leading to a mean DR ap-
proaching 0.5. All experiments were carried out in accordance with
the guidelines of the Australian Code for the Care and Use of Ani-
mals for Scienti¢c Purposes.
2.2. In vitro PPIase assay
Three groups of 20 chicks were trained as described above. One
group was injected with 10 Wl of a 5 nM CyH solution (MeA-trained/
CyH), the second group was injected with 10 Wl of a 5 nM [Me-
Val4]CyA solution (MeA-trained/[MeVal4]CyA) in the left and right
hemisphere immediately after training. Since all drugs used for injec-
tion were prepared from a 1 mM stock solution of the drug dissolved
in DMSO, the third group was injected with 10 Wl of a 0.000005%
DMSO/saline (MeA-trained/DMSO).
After 90 min, the chicks were decapitated with their heads imme-
diately dropped into liquid nitrogen for about 5 s. Five brains from
the MeA-trained/CyH group (0.1791 g total frozen weight), from the
MeA-trained/[MeVal4]CyA group (0.198 g total frozen weight), and
from the MeA-trained/DMSO group (0.194 g total frozen weight),
were harvested. The frozen brains were then transferred onto dry
ice and stored in a 380‡C freezer. The forebrains were subsequently
dissected out, and the IMHV/neostriatal, hippocampal regions, right
to the surface of the forebrain (V7 mm by 5 mm by 5 mm), were cut
out, for each of the two groups. Only the left hemisphere, previously
shown to be most prominent in LTM formation, was analyzed for the
PPIase activity.
Tissues from the two groups were rinsed very brie£y (V5 s) in ice-
cold washing bu¡er (0.32 M sucrose; 1 mM K2HPO4 ; 1 mM EDTA;
4 g/l of MgCl2, 0.02% NaN3, 1.2 mM EGTA, 1 mM CaCl2, 1 mM
NaF, 1 mM sodium vanadate, 10 Wl/ml of protease inhibitor cocktail
(Sigma P8340, Castle Hill, Australia)). Immediately thereafter, tissues
were homogenized in 5 ml of washing bu¡er (containing 10 Wl/ml of
protease inhibitor cocktail) with 12 strokes in a mechanical rotatory
glass-te£on homogenizer (John Morris Scienti¢c Instruments, Mel-
bourne, Australia) set at 1500 rpm. 1 ml of each extract was then
mixed with 100 Wl of Nonidet P-40 and re-homogenized using a man-
ual glass-glass homogenizer (Kontes, NJ). The extract was cleared by
centrifugation in an Eppendorf centrifuge for 20 min. Protein content
from the cleared extracts was determined using both the using the
Bio-Rad Bradford assay kit (Bio-Rad, Regent Park, Australia) and
absorbance at 280 nM and then diluted to 100 Wg protein/ml. These
extracts were then used for the PPIase assays.
All enzymatic reactions were conducted at 10‡C. Enzyme activity in
the cleared extracts was measured essentially as described by [16]. In
brief, a mixture of 50 Wl of cleared extract was stirred with 1.5 ml of
bu¡er (50 mM HEPES, 100 mM NaCl, pH 8.0) and 100 Wl of K-
chymotrypsin (dissolved in 1 mM HCl to a concentration of 25 mg/
ml) in a quartz cuvette and cooled to 10‡C. Three cuvettes of mixtures
prepared from cleared extracts of two groups were prepared in any
one experiment performed together with two cuvettes of control mix-
tures: without any extract and without any extract but with 50 Wl of
200 mg/ml BSA solution. The reaction was started with the addition
of 3 Wl of peptide substrate and the change in absorbance at 390 nm
was monitored every 3.75 s for each cuvette for 600 s, with the mix-
tures continuously being stirred. (The peptide substrate had been dis-
solved in 470 mM LiCl in tri£uoroethanol to a concentration of 14.5
mg/ml and allowed to come to equilibrium for 24 h.) PPIase activity,
which was not inhibitable by FK506, was measured by pre-incubating
the extracts with 167 WM FK506 for 20 min before the assay.
To monitor the extent of inhibition of PPIases in the forebrain
extracts by the injected drugs, brain extracts of each group were
pre-incubated for 20 min with saturating concentrations of CyA (10
Wl of 500 WM CyA per 50 Wl extract) in addition to FK506 to inhibit
most PPIase activity in the cleared extracts used.
3. Results
In an initial experiment groups of chicks were administered
one of various concentrations of [MeVal4]CyA or a 5 nM
concentration of CyH or CyA immediately after training,
and were tested for retention following an interval of 180
min. As shown in Fig. 1, various concentrations of [Me-
Val4]CyA caused marked retention de¢cits. Di¡erences be-
tween group means were analyzed using a one-way ANOVA
[17], which revealed signi¢cant di¡erences between groups
(F9;189 = 6.887, P6 0.001). Post-hoc Dunnett’s tests (K= 0.05)
[17], comparing each experimental group with the CyH-
treated group, revealed a signi¢cant e¡ect for all groups re-
ceiving a concentration of 0.1 nM [MeVal4]CyA (= 1 fmol) or
greater and for the group which received 5 nM CyA (= 50
fmol).
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Fig. 1. Dose response for [MeVal4]CyA. All concentrations of [Me-
Val4]CyA were administered intracranially (10 Wl/hemisphere) imme-
diately following training, with chicks being tested for retention fol-
lowing an interval of 180 min. The results are compared against the
e¡ect of 5 nM CyA and 5 nM CyH (= 50 fmol of cyclosporin ad-
ministered). * Denotes those groups which di¡ered signi¢cantly
(K= 0.05) from the CyH-treated chicks.
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For the purposes of comparison with earlier studies using
50 fmol of CyA [12] 50 fmol of [MeVal4]CyA were adminis-
tered bilaterally to groups of chicks at various times relative
to training on the passive-avoidance task. Control groups
were administered the EtOH vehicle at corresponding times,
with retention in all groups being tested 180 min after the
training event. The results are shown in Fig. 2. A two-way
ANOVA revealed signi¢cant main e¡ects for drug condition
(F1;362 = 19.86, P6 0.001) and time of administration
(F9;362 = 2.27, P6 0.05) and a signi¢cant drug condition by
time of administration interaction e¡ect (F9;362 = 2.44,
P6 0.05). Post-hoc tests of simple main e¡ects were signi¢-
cant (P6 0.05) across drug condition for groups injected at all
times ranging from 310 min to +20 min relative to training,
and, across times of administration, for groups of chicks ad-
ministered [MeVal4]CyA. These data demonstrate that mem-
ory formation in the chick is sensitive to [MeVal4]CyA only
within a speci¢c window of administration. This window of
sensitivity is similar to that previously obtained for CyA (310
to +40 min), although CyA is e¡ective for a longer time after
training, perhaps indicating that it may act more rapidly than
does [MeVal4]CyA.
To once more facilitate direct comparison with earlier stud-
ies using 50 fmol of CyA [12] and 50 fmol of CyH, 50 fmol of
[MeVal4]CyA was administered bilaterally to groups of chicks
immediately following training on the passive-avoidance task,
with retention being tested following various intervals. To
control for non-speci¢c drug e¡ects, one group of chicks
was also administered 50 fmol of CyH and tested at 180
min post training. The results are shown in Fig. 3. A one-
way ANOVA revealed signi¢cant di¡erences in retention
among the groups (F7;136 = 3.405, P6 0.01), with post-hoc
Dunnett’s tests (K= 0.05), comparing each experimental group
with the control group, administered 50 fmol of CyH and
tested 180 min post training, revealing signi¢cant de¢cits for
all time points after 80 min.
Finally, 50 fmol of either [MeAla6]CyA or [MeIle4]CyA was
administered as described for the previous experiment. As
shown in Fig. 4 both compounds were found to produce re-
tention de¢cits similar to those induced by 50 fmol of [Me-
Val4]CyA and CyA (also included in Fig. 4). A two-way AN-
OVA revealed a signi¢cant main e¡ect for time of test
(F4;294 = 10.89, P6 0.001), but no signi¢cant main e¡ect for
drug (P = 0.238) and no interaction e¡ect between drug and
time of test (P = 0.968). Hence, retention de¢cits induced by
all three CyA analogues and by CyA are statistically indistin-
guishable and a non-speci¢c drug e¡ect is unlikely to account
for the e¡ect of any single agent.
Total PPIase activity was observed in the cleared extracts
from both groups of chicks when compared with the control
reaction (without addition of extracts). Fifty microliters of the
cleared extracts with a protein concentration of 100 Wg/ml
each were used. Since the substrate used in this assay is iso-
merized by cyclophilins as well as by FKBPs, we performed
these experiments after pre-incubation with FK506 (Fig. 5).
The rate of reaction is expressed as the rate of absorbance
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Fig. 4. Comparison of time courses obtained using various CyA
analogues. Groups of chicks were administered a 5 nM concentra-
tion (50 fmol) of either [MeIle4]CyA or [MeAla6]CyA, immediately
after training on the passive-avoidance task, with retention being
tested following various intervals. Results obtained previously using
CyA (5 nM) and [MeVal4]CyA (5 nM) are included to facilitate
comparison across drug conditions. No signi¢cant di¡erences were
obtained.
Fig. 3. Time course for the development of retention de¢cits follow-
ing administration of [MeVal4]CyA. A 5 nM concentration of either
[MeVal4]CyA or CyH was administered intracranially (10 Wl/hemi-
sphere, 50 fmol of Cy) immediately after training. Groups of [Me-
Val4]CyA-treated chicks were tested for retention following various
intervals, and are compared with the CyH-treated group, which was
tested at 180 min post training. * Denotes those groups which dif-
fered signi¢cantly (K= 0.05) from the CyH-treated chicks.
Fig. 2. Time of administration study for [MeVal4]CyA. A 5 nM
concentration of either [MeVal4]CyA or the EtoH vehicle was ad-
ministered intracranially (10 Wl/hemisphere, 50 fmol of Cy) at vari-
ous times relative to training, with all chicks being tested for reten-
tion after an interval of 180 min. * Denotes those [MeVal4]CyA-
treated groups which di¡ered signi¢cantly (K= 0.05) from the corre-
sponding EtoH-treated group.
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change as concentrations of all constituents in the di¡erent
reaction mixtures were kept constant.
The rate of absorbance change in the MeA-trained/CyH
group (0.0053 vA/min) was similar to that of the MeA-
trained/saline group (0.0053 vA/min) and approximately
2 times the rate of absorbance change in the MeA-trained/
[MeVal4]CyA group (0.0039 vA/min). The rate of absorbance
change in the MeA-trained/[MeVal4]CyA group approached
the rate measured for the control (0.0024 vA/min) strongly
suggesting that administration of the drug led to inhibition of
(a) Cy-sensitive PPIase(s). Fig. 5 depicts a representative of
¢ve independent experiments. The extract-free mixture con-
taining BSA did not di¡er signi¢cantly in the rate from the
extract-free mixture containing washing bu¡er. All the cleared
extracts containing CyA had rates of absorbance change
which closely matched the background rates of the controls,
indicating total inhibition of PPIase activity in the mixtures
(data not shown).
4. Discussion
The intracranial administration of various concentrations
of [MeVal4]CyA into the hyperstriatal/neostriatal complex
was found to produce signi¢cant retention de¢cits in groups
of chicks trained on an established, single-trial, passive-avoid-
ance task. The e¡ects were obtained only when the drug was
administered within a temporally de¢ned window of sensitiv-
ity surrounding the time of training. Further, when 10 Wl of a
5 nM concentration of either [MeVal4]CyA, [MeIle4]CyA or
[MeAla6]CyA (50 fmol each) was administered immediately
after training, retention de¢cits ¢rst became signi¢cant after
80 min and remained signi¢cant for at least 24 h. This time
course is essentially identical to that induced by CyA [12].
Memory for the passive-avoidance task in the chick has
been shown to involve three distinct stages: a short-term
stage, formed by 5 min and decaying 10 min post training;
an intermediate-term stage, formed by 20 min and decaying
50 min post training; and a long-term stage, available by 60
min post training [18^20]. Since retention levels following the
administration of all agents remain high for at least 60 min
after training, within the framework of this model both CyA
and various non-immunosuppressive analogues would appear
to selectively disrupt long-term memory, leaving earlier mem-
ory stages intact. Interestingly, recently obtained data suggest
that the same e¡ects can be obtained when the drugs are
exclusively administered to the left hemisphere, whereas ad-
ministration to the right hemisphere only does not lead to an
amnestic e¡ect (Bennett, Zhao, Lawen and Ng, unpublished
results).
CyA is known to disrupt both the PPIase activity of cyclo-
philins and the phosphatase activity of CaN [1,2,21], and has
also been reported to bind to a multidrug resistance (MDR)-
related P-glycoprotein [22]. The temporal speci¢city of the
data, as the low drug concentrations required, as well as the
speci¢c window of e¡ective concentrations, would appear to
exclude any non-speci¢c toxicological e¡ects of the drugs em-
ployed and, because CyH binds as well as CyA to the MDR-
related P-glycoprotein [22], the failure of CyH to induce mem-
ory loss in this or our previous study [12] suggests that the
e¡ects of CyA are not mediated by binding of CyA to the P-
glycoprotein. All literature data so far suggest that the non-
immunosuppressive CyA analogues employed in this study do
not inhibit calcineurin either in vitro or in vivo [6^8,23^27].
Administration of 50 fmol of [MeVal4]CyA was su⁄cient to
inhibit most of the CyA-sensitive PPIase activities in that area
of the brain. As is evident from Fig. 5 by no means all cyclo-
philin activities are inhibited in our extracts. However, these
data show some cyclophilin inhibition, including obviously at
least one activity necessary for memory formation. Together
with the amnestic e¡ects obtained with the three drugs these
data strongly support the conclusion that CyA-sensitive
PPIase activities are required for the formation of a relatively
late stage of memory in the day-old chick. While a concurrent
role for CaN has not yet been adequately tested, due to the
non-speci¢city of all available inhibitory agents, this supports
previous claims that the ubiquitous distribution of cyclophil-
ins in the brain denotes important but as yet largely uniden-
ti¢ed roles independently of their pharmacologically-induced
inhibition of CaN [28].
Besides its PPIase activity, cyclophilin A has also been sug-
gested to exert a chaperone activity. This interpretation results
from testing cyclophilin A in the in vitro folding of carbonic
anhydrase [29,30] and from studies of mutants of the ninaA
protein [31], although a recent report suggests that the ob-
served e¡ects can be contributed to PPIase activity [32]. In-
direct evidence for its function as a chaperone is, however, the
presence of the decameric unit of cyclophilin A-CyA com-
plexes in crystals of the complex, in a manner reminiscent
of other chaperones and heat shock proteins [33]. Therefore,
we cannot totally exclude from our data a chaperone-like
function of a cyclophilin in memory formation.
Our data, while providing strong evidence of a role for
cyclophilin in memory formation, do not eliminate the possi-
bility of a role for CaN in information storage processes.
There is evidence that CaN is involved in the induction of
LTD [34^36], an important cellular model of memory and,
given evidence that other phosphatases contribute to memory
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Fig. 5. In vitro cyclophilin PPIase activity of brain extracts. All ex-
tracts (50 Wl each) were pre-incubated with 167 WM FK506 for 20
min on ice. The extracts were then mixed with 1.5 ml of bu¡er and
100 Wl of K-chymotrypsin and allowed to reach 10‡C. The reaction
was started by the addition of 20 Wl of substrate and was monitored
at 390 nm every 0.5 s for 500 s. (1) Control assay with addition of
brain extract from MeA-trained and CyH-treated chicken; (2) con-
trol assay with addition of brain extract from MeA-trained and
DMSO-treated chicken; (3) assay with addition of brain extract
from MeA-trained and [MeVal4]CyA-treated chicken; (4) assay with
addition of brain extract from MeA-trained and CyH-treated chick-
en that has undergone pre-incubation with saturating amounts of
CyA; (5) control assay without addition of extract.
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formation in Drosophila [37], rodents [38], and the neonate
chick [39], it remains likely that evidence of a role for CaN
in memory formation will be forthcoming. Further studies,
currently under way in our laboratory, are presently address-
ing this issue using alternative inhibitors for CaN, such as
FK506 and the pyrethroid deltamethrin. Preliminary evidence
suggests that CaN may indeed play a role in memory forma-
tion, as may the class of immunophilins inhibited by FK506
(Bennett, Zhao, Lawen and Ng, unpublished results), but this
is yet to be adequately con¢rmed and the temporal parameters
of the e¡ects are not yet established.
A role for cyclophilins in memory is consistent with un-
equivocal evidence that protein biosynthesis, and therefore
folding and possibly transport, is essential for long-term mem-
ory formation in various species [40]. Further research will be
needed to clarify the exact nature of the role played by cyclo-
philins in memory formation. Although cyclophilins have
been reported to have a role in HIV infectivity [7,11] and in
the folding of proteins imported into mitochondria [10], few
physiological roles for these enzymes have been identi¢ed. It is
of interest, however, that neurotrophic actions of CyA and
FK506, previously attributed tentatively to the inhibition of
CaN [41], have also recently been described to be mediated by
inhibition of PPIase activity [9]. Additional roles for PPIase
enzymes seem likely to emerge now that more speci¢c inhib-
itory agents are available. Our laboratory is presently trying
to identify the cyclophilin isozyme necessary for the formation
of long-term memory.
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